bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.08.20.671283

Proteomic analysis of Mycobacterium tuberculosis lacking a putative short-chain dehydrogenase (Rv0148)

Abstract

Mycobacterium tuberculosis (Mtb) is an intracellular pathogen that survives in host cells by resisting hostile antimicrobial defenses. However, the molecules and mechanisms that contribute to Mtbs intracellular survival are not fully understood. We have previously reported that Rv0148, a putative short-chain dehydrogenase/reductase, plays a significant role in Mtb stress response and virulence in in vitro and in vivo models. To further understand the role of Rv0148 in regulating global functions of Mtb, we performed comparative proteomic analysis between pathogenic wild-type (WT) and{Delta} rv0148 mutant strains. Our mass spectrometry-based proteomics approach identified a total of 738 and 469 proteins, respectively, in the WT and{Delta} rv0148 mutant, with distinct expression patterns. Gene Ontology analysis revealed significant enrichment of proteins involved in biological processes such as resistant to host immune response and protein homeostasis in{Delta} rv0148 mutant, while peptidoglycan biosynthesis and ribosomal metabolism pathways were downregulated. Further network analysis revealed dysregulation of proteins involved in bacterial stress response, cell wall components, ribosomal and secretory proteins, suggesting impaired translational machinery in{Delta} rv0148 mutant. Functional categorization of differentially regulated proteins in{Delta} rv0148 mutant showed broad reprogramming in intermediary metabolism, stress adaptation, and secretion. These findings indicate that Rv0148 functions as a global regulatory node, which influences remodeling of cell wall components and bacterial physiology, potentially balancing survival and stress adaptation mechanisms in Mtb. IMPORTANCEMycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is a notorious pathogen that can resist the hostile host environment to survive intracellularly and to cause disease. However, the molecular determinants that contribute to Mtbs adaptation to resist the host-imposed stress conditions are not fully understood. Previous in vitro and in vivo studies have shown that Rv0148, a putative short-chain dehydrogenase/reductase, is involved in Mtb stress response and virulence. In this study, the genome wide proteomic profile of Mtb mutant lacking Rv0148 ({Delta}rv0148) was investigated. Compared to the wild type Mtb strain, striking changes in proteome profile of{Delta} rv0148 mutant was noted. Proteins involved in the ESX secretion system, stress response, ribosomal protein metabolism and cell wall components were significantly affected in the{Delta} rv0148 mutant. The impact of these changes in biological functions that link Rv0148s role in Mtbs adaptation to stress conditions is discussed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Subbian, S., Bhargavi, G., Deenadayalan, A., Palaniyandi, K.. 2025-08-20. Proteomic analysis of Mycobacterium tuberculosis lacking a putative short-chain dehydrogenase (Rv0148). https://doi.org/10.1101/2025.08.20.671283

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗